Biogen Idec to Present at the DB Access BioFEST Conference

Mon Nov 26, 2012 4:01pm EST

* Reuters is not responsible for the content in this press release.

Biogen Idec to Present at the DB Access BioFEST Conference

Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at the DB Access BioFEST Conference will be webcast live on Monday, December 3, 2012 at 8:25 a.m. ET. To access the live webcast, please visit Biogen Idec’s Investors section at www.biogenidec.com. An archived version of the webcast will be available for 14 days following the presentation.

About Biogen Idec

Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the world’s oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $5 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com.

Biogen Idec
Karen Jewell, 781-464-2442
Investor Relations

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.